{
    "case_number": "CAC-UDRP-108854",
    "time_of_filling": "2026-07-22 09:05:53",
    "domain_names": [
        "spiriva.store"
    ],
    "case_administrator": "Olga Dvořáková (Case admin)",
    "complainant": [
        "Boehringer Ingelheim Pharma GmbH & Co KG"
    ],
    "complainant_representative": "NAMESHIELD S.A.S.",
    "respondent": [
        "Gina  Yu"
    ],
    "respondent_representative": null,
    "factual_background": "<p>The Complainant is a German family-owned pharmaceutical group of companies with roots dating back to 1885. Since then, it has developed into a global research-driven pharmaceutical enterprise operating in the areas of human pharmaceuticals and animal health. The Complainant currently employs approximately 54,300 people and, in 2025, achieved net sales of approximately EUR 27.8 billion.<\/p>\n<p>The Complainant uses the SPIRIVA Trademark in connection with its pharmaceutical product containing tiotropium bromide, which is used for the treatment of chronic obstructive pulmonary disease (COPD). The SPIRIVA product has been marketed under the SPIRIVA Trademark in numerous countries.<\/p>\n<p>The disputed domain name was registered on 19 July 2026. According to the Registrar Verification, the Respondent is Gina Yu, located in China.<\/p>\n<p>The disputed domain name currently resolves to the Registrar's parking page, indicating that the domain name is registered and may be available for acquisition.<\/p>",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
    "no_response_filed": "<p>The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.<\/p>\n<p>No administratively compliant Response has been filed.<\/p>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Ivett Paulovics"
    ],
    "date_of_panel_decision": "2026-08-22 00:00:00",
    "informal_english_translation": "<p>The Complainant is the owner of several trademark registrations for the SPIRIVA trademark, including in particular:<\/p>\n<ul>\n<li>International Trademark Registration No. 692353 for SPIRIVA, registered on 1 April 1998 in Class 5; and<\/li>\n<li>European Union Trademark Registration No. 000789529 for SPIRIVA, registered on 16 June 1999 in Class 5.<\/li>\n<\/ul>\n<p>The Complainant has also submitted evidence of longstanding use of the SPIRIVA trademark in connection with pharmaceutical products, including a Trademark Clearinghouse proof-of-use declaration and supporting documentation.<\/p>\n<p>The Complainant also owns the domain name &lt;spiriva.com&gt;, registered since 15 February 1999.<\/p>\n<p>The Complainant's above-mentioned rights are hereinafter collectively referred to as the SPIRIVA Trademark.<\/p>",
    "decision_domains": {
        "spiriva.store": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}